Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Halozyme Therapeutics, Inc. - Common Stock (NQ:HALO)

69.24 +0.92 (+1.35%)

Streaming Delayed Price Updated: 11:52 AM EDT, May 26, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	352,404
Open	68.96
Bid (Size)	69.24 (300)
Ask (Size)	69.34 (100)
Prev. Close	68.32
Today's Range	68.43 - 69.36
52wk Range	51.06 - 82.22
Shares Outstanding	142,334,900
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Halozyme Therapeutics’s Q1 Earnings Call: Our Top 5 Analyst Questions

May 18, 2026

Halozyme Therapeutics’ first quarter results for 2026 were met with a positive market response, underpinned by substantial royalty revenue growth and the exp...

Via StockStory

Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know

May 13, 2026

What Happened? A number of stocks fell in the afternoon session after the April PPI report showed wholesale inflation accelerating to 6% annually, with servi...

Via StockStory

Performance

YTD	-1.5%	-1.5%
1 Month	+7.4%	+7.4%
3 Month	-2.0%	-2.0%
6 Month	-6.4%	-6.4%
1 Year	+27.2%	+27.2%

More News

Therapeutics Stocks Q1 Recap: Benchmarking Halozyme Therapeutics (NASDAQ:HALO)

May 12, 2026

Via StockStory

HALO Q1 Deep Dive: Royalty Expansion and Pipeline Progress Shape 2026 Outlook

May 12, 2026

Via StockStory

Halozyme Therapeutics (NASDAQ:HALO) Surges After Q1 Beat, Launches $1 Billion Buyback ↗

May 11, 2026

Via Chartmill

Halozyme Therapeutics Inc (NASDAQ:HALO) Presents a Compelling Value Investment Case ↗

March 06, 2026

Via Chartmill

Halozyme Therapeutics Inc (NASDAQ:HALO) Reports Mixed Q4 2025 Results with Revenue Beat and Unexpected Loss ↗

February 17, 2026

Via Chartmill

Halozyme (HALO) Q1 2026 Earnings Transcript ↗

May 11, 2026

Via The Motley Fool

Halozyme Therapeutics Q1 Earnings Call Highlights ↗

May 11, 2026

Via MarketBeat

Halozyme Therapeutics’s (NASDAQ:HALO) Q1 CY2026 Sales Top Estimates

May 11, 2026

Via StockStory

HALOZYME THERAPEUTICS INC (NASDAQ:HALO): A GARP Stock with Strong Growth and Reasonable Valuation ↗

February 17, 2026

Via Chartmill

Halozyme Therapeutics Inc (NASDAQ:HALO) Presents a Compelling Growth and Technical Setup ↗

January 29, 2026

Via Chartmill

Halozyme Therapeutics Earnings: What To Look For From HALO

May 09, 2026

Via StockStory

1 of Wall Street’s Favorite Stock with Exciting Potential and 2 That Underwhelm

April 21, 2026

Via StockStory

3 Cash-Producing Stocks with Exciting Potential

April 10, 2026

Via StockStory

2 Small-Cap Stocks with Solid Fundamentals and 1 We Ignore

April 09, 2026

Via StockStory

1 Small-Cap Stock for Long-Term Investors and 2 We Brush Off

April 08, 2026

Via StockStory

Unpacking Q4 Earnings: Halozyme Therapeutics (NASDAQ:HALO) In The Context Of Other Therapeutics Stocks

March 24, 2026

Via StockStory

2 Reasons to Like HALO (and 1 Not So Much)

February 24, 2026

Via StockStory

Halozyme (HALO) Q4 2025 Earnings Call Transcript ↗

February 17, 2026

Via The Motley Fool

Halozyme Therapeutics (NASDAQ:HALO) Surprises With Q4 CY2025 Sales

February 17, 2026

Via StockStory

Acadia Healthcare, Hims & Hers Health, RadNet, Halozyme Therapeutics, and Privia Health Shares Are Soaring, What You Need To Know

February 13, 2026

Via StockStory

3 Small-Cap Stocks with Solid Fundamentals

February 08, 2026

Via StockStory

3 Growth Stocks Set to Flourish

February 01, 2026

Via StockStory

A Look Back at Therapeutics Stocks’ Q3 Earnings: United Therapeutics (NASDAQ:UTHR) Vs The Rest Of The Pack

January 29, 2026

Via StockStory

Frequently Asked Questions

Is Halozyme Therapeutics, Inc. - Common Stock publicly traded?

Yes, Halozyme Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Halozyme Therapeutics, Inc. - Common Stock trade on?

Halozyme Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Halozyme Therapeutics, Inc. - Common Stock?

The ticker symbol for Halozyme Therapeutics, Inc. - Common Stock is HALO on the Nasdaq Stock Market

What is the current price of Halozyme Therapeutics, Inc. - Common Stock?

The current price of Halozyme Therapeutics, Inc. - Common Stock is 69.24

When was Halozyme Therapeutics, Inc. - Common Stock last traded?

The last trade of Halozyme Therapeutics, Inc. - Common Stock was at 05/26/26 11:52 AM ET

What is the market capitalization of Halozyme Therapeutics, Inc. - Common Stock?

The market capitalization of Halozyme Therapeutics, Inc. - Common Stock is 9.86B

How many shares of Halozyme Therapeutics, Inc. - Common Stock are outstanding?

Halozyme Therapeutics, Inc. - Common Stock has 10B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.